REPLIMUNE GROUP, INC. Depreciation and Amortization
REPLIMUNE GROUP, INC. (REPL) reported Depreciation and Amortization of $937.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-08-14
- REPLIMUNE GROUP, INC. depreciation, depletion and amortization for the quarter ending 2026-06-30 was $937.00K, a 7.33% increase year-over-year.
- REPLIMUNE GROUP, INC. depreciation, depletion and amortization for the quarter ending 2026-03-31 was $769.00K, a 9.32% decline year-over-year.
- REPLIMUNE GROUP, INC. depreciation, depletion and amortization for the quarter ending 2025-12-31 was $800.00K, a 20.00% decline year-over-year.
- REPLIMUNE GROUP, INC. depreciation, depletion and amortization for the quarter ending 2025-09-30 was $800.00K, a 11.11% decline year-over-year.
- REPLIMUNE GROUP, INC. depreciation, depletion and amortization for fiscal 2026 was $3.33M, a 4.85% decline from fiscal 2025.
- REPLIMUNE GROUP, INC. depreciation, depletion and amortization for fiscal 2025 was $3.50M, a 31.90% increase from fiscal 2024.
- REPLIMUNE GROUP, INC. depreciation, depletion and amortization for fiscal 2024 was $2.65M, a 8.50% increase from fiscal 2023.
- REPLIMUNE GROUP, INC. depreciation, depletion and amortization for fiscal 2023 was $2.45M, a 13.97% increase from fiscal 2022.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $937.00K 10-Q · filed 2026-08-14 | $1.71M derived: sum of 2 quarters · filed 2026-08-14 | $2.51M derived: sum of 3 quarters · filed 2026-08-14 | $3.31M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $769.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $1.57M derived: sum of 2 quarters · filed 2026-06-29 | $2.37M derived: sum of 3 quarters · filed 2026-06-29 | $3.33M 10-K · filed 2026-06-29 |
| 2025-12-31 | $800.00K 10-Q · filed 2026-02-03 | $1.60M derived: sum of 2 quarters · filed 2026-02-03 | $2.56M 10-Q · filed 2026-02-03 | $3.32M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-09-30 | $800.00K 10-Q · filed 2025-11-06 | $1.72M 10-Q · filed 2025-11-06 | $2.52M derived: sum of 3 quarters · filed 2026-08-14 | $3.52M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $873.00K 10-Q · filed 2026-08-14 | $1.72M derived: sum of 2 quarters · filed 2026-08-14 | $2.72M derived: sum of 3 quarters · filed 2026-08-14 | $3.62M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $848.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $1.85M derived: sum of 2 quarters · filed 2026-06-29 | $2.75M derived: sum of 3 quarters · filed 2026-06-29 | $3.50M 10-K · filed 2026-06-29 |
| 2024-12-31 | $1.00M 10-Q · filed 2026-02-03 | $1.90M derived: sum of 2 quarters · filed 2026-02-03 | $2.65M 10-Q · filed 2026-02-03 | $3.34M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | $900.00K 10-Q · filed 2025-11-06 | $1.66M 10-Q · filed 2025-11-06 | $2.34M derived: sum of 3 quarters · filed 2025-11-06 | $3.04M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $736.00K 10-Q · filed 2025-08-07 | $1.44M derived: sum of 2 quarters · filed 2025-08-07 | $2.14M derived: sum of 3 quarters · filed 2025-08-07 | $2.84M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $705.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-22 | $1.41M derived: sum of 2 quarters · filed 2025-05-22 | $2.10M derived: sum of 3 quarters · filed 2025-05-22 | $2.65M 10-K · filed 2025-05-22 |
| 2023-12-31 | $700.00K 10-Q · filed 2025-02-12 | $1.40M derived: sum of 2 quarters · filed 2025-02-12 | $1.95M 10-Q · filed 2025-02-12 | $2.55M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | $700.00K 10-Q · filed 2024-11-12 | $1.27M 10-Q · filed 2024-11-12 | $1.85M derived: sum of 3 quarters · filed 2024-11-12 | $2.53M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $621.00K 10-Q · filed 2024-08-08 | $1.15M derived: sum of 2 quarters · filed 2024-08-08 | $1.83M derived: sum of 3 quarters · filed 2024-08-08 | $2.45M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $528.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-16 | $1.21M derived: sum of 2 quarters · filed 2024-05-16 | $1.83M derived: sum of 3 quarters · filed 2024-05-16 | $2.45M 10-K · filed 2024-05-16 |
| 2022-12-31 | $682.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | $1.30M derived: sum of 2 quarters · filed 2024-02-08 | $1.92M 10-Q · filed 2024-02-08 | $2.47M derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-09-30 | $617.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-07 | $1.24M 10-Q · filed 2023-11-07 | $1.79M derived: sum of 3 quarters · filed 2023-11-07 | $2.33M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $620.00K 10-Q · filed 2023-08-03 | $1.17M derived: sum of 2 quarters · filed 2023-08-03 | $1.72M derived: sum of 3 quarters · filed 2023-08-03 | $2.25M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $549.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-18 | $1.10M derived: sum of 2 quarters · filed 2023-05-18 | $1.63M derived: sum of 3 quarters · filed 2023-05-18 | $2.15M 10-K · filed 2023-05-18 |
| 2021-12-31 | $548.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09 | $1.08M derived: sum of 2 quarters · filed 2023-02-09 | $1.60M 10-Q · filed 2023-02-09 | $2.09M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-09-30 | $532.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-03 | $1.05M 10-Q · filed 2022-11-03 | $1.54M derived: sum of 3 quarters · filed 2022-11-03 | $1.95M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $518.00K 10-Q · filed 2022-08-04 | $1.01M derived: sum of 2 quarters · filed 2022-08-04 | $1.41M derived: sum of 3 quarters · filed 2022-08-04 | $1.84M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $494.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-19 | $896.00K derived: sum of 2 quarters · filed 2022-05-19 | $1.32M derived: sum of 3 quarters · filed 2022-05-19 | $1.71M 10-K · filed 2022-05-19 |
| 2020-12-31 | $402.00K 10-Q · filed 2021-02-04 | $827.00K derived: sum of 2 quarters · filed 2021-02-04 | $1.22M 10-Q · filed 2022-02-03 | $1.56M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-09-30 | $425.00K 10-Q · filed 2020-11-05 | $816.00K 10-Q · filed 2021-11-04 | $1.16M derived: sum of 3 quarters · filed 2021-08-06 | $1.26M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-06-30 | $391.00K 10-Q · filed 2021-08-06 | $733.00K derived: sum of 2 quarters · filed 2021-08-06 | $840.00K derived: sum of 3 quarters · filed 2021-08-06 | $882.00K derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $342.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-20 | $449.00K derived: sum of 2 quarters · filed 2021-05-20 | $491.00K derived: sum of 3 quarters · filed 2021-05-20 | $533.00K 10-K · filed 2021-05-20 |
| 2019-12-31 | $107.00K 10-Q · filed 2021-02-04 | $149.00K derived: sum of 2 quarters · filed 2021-02-04 | $191.00K 10-Q · filed 2021-02-04 | $233.00K derived: sum of 4 quarters · filed 2021-02-04 |
| 2019-09-30 | $42.00K 10-Q · filed 2020-11-05 | $84.00K 10-Q · filed 2020-11-05 | $126.00K derived: sum of 3 quarters · filed 2020-11-05 | $163.00K derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $42.00K 10-Q · filed 2020-08-07 | $84.00K derived: sum of 2 quarters · filed 2020-08-07 | $121.00K derived: sum of 3 quarters · filed 2020-08-07 | $157.00K derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-03 | $79.00K derived: sum of 2 quarters · filed 2020-06-03 | $115.00K derived: sum of 3 quarters · filed 2020-06-03 | $148.00K 10-K · filed 2020-06-03 |
| 2018-12-31 | $37.00K 10-Q · filed 2020-02-13 | $73.00K derived: sum of 2 quarters · filed 2020-02-13 | $106.00K 10-Q · filed 2020-02-13 | $134.00K derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-09-30 | $36.00K 10-Q · filed 2019-11-12 | $69.00K 10-Q · filed 2019-11-12 | $97.00K derived: sum of 3 quarters · filed 2020-06-03 | $128.00K derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-06-30 | $33.00K 10-Q · filed 2019-08-14 | $61.00K derived: sum of 2 quarters · filed 2020-06-03 | $92.00K derived: sum of 3 quarters · filed 2020-06-03 | $119.00K derived: sum of 4 quarters · filed 2020-06-03 |
| 2018-03-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-03 | $59.00K derived: sum of 2 quarters · filed 2020-06-03 | $86.00K derived: sum of 3 quarters · filed 2020-06-03 | $109.00K 10-K · filed 2020-06-03 |
| 2017-12-31 | $31.00K 10-Q · filed 2019-02-14 | $58.00K derived: sum of 2 quarters · filed 2019-02-14 | $81.00K 10-Q · filed 2019-02-14 | |
| 2017-09-30 | $27.00K 10-Q · filed 2018-11-14 | $50.00K 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | $23.00K 10-Q · filed 2018-08-30 | |||
| 2017-03-31 | $122.00K 10-K · filed 2019-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |